CTRI/2018/10/016227招募中4 期
0.1% Nepafenac vs 0.09% Bromfenac Eye Drops in Post Laser Peripheral Iridotomy Inflammation- A Randomised Controlled Study
试验速览
- 阶段
- 4 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Primary angle closure suspects
- •2)Primary angle closure not started in anti-glaucoma medications post laser peripheral iridotomy
- •3)Best corrected visual acuity of 6/12 or better
排除标准
- •1)Corneal pathology like dry eyes
- •2)Significant cataract which is obscuring undilated disc evaluation
- •3)PAC patients who are started on glaucoma medication before or immediately after LPI
- •4)PACG and Secondary angle closure glaucoma
- •5)History of any topical therapy including NSAIDâ??s within the past 30 days prior to LPI
- •6)Patient on systemic steroids or non-steroidal anti-inflammatory drugs
- •7) Any History of Laser or intraocular surgery
- •8)Pregnant or nursing mothers
- •9)Monocular patients
- •10)Any evidence of uveitis (old or new)
- •11) Patients with bleeding in the eye after the LPI
研究者
相似试验
尚未招募
3 期
Comparison of nepafenac 0.1% and 0.3% eye drops in management of DMECTRI/2021/11/038069JIPMER PONDICHERRY
已完成
不适用
To compare efficacy of two drugs in maintaining pupillary dilatation during Phaco emulsification surgery.CTRI/2018/01/011277I160
进行中（未招募）
1 期
To compare the efficacy of bromfenac ophthalmic solution 0.09% to dexamethasone ophthalmic solution 0.1% for reducing postoperative inflammation after cataract surgery.Postoperative ocular inflammation after cataract surgeryMedDRA version: 20.0Level: PTClassification code 10015943Term: Eye inflammationSystem Organ Class: 10015919 - Eye disordersEUCTR2016-004358-14-ITAZIENDA OSPEDALIERA ARCISPEDALE SANTA MARIA NUOVA/IRCCS DI REGGIO EMILIA76
已完成
不适用
Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal InjectionsPainNCT03406689University Hospital of Patras99
进行中（未招募）
1 期
epafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo (Nepafenac Vehicle) for the Prevention and Treatment of Ocular Inflammation and Ocular Pain Associated with Cataract Surgery. European Study.ocular pain and inflammation associated with cataract extraction and intraocular lens implantationEUCTR2005-002647-35-GBAlcon Research, Ltd